Junyong Zhao

799 total citations
26 papers, 621 citations indexed

About

Junyong Zhao is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junyong Zhao has authored 26 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junyong Zhao's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and RNA Research and Splicing (3 papers). Junyong Zhao is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and RNA Research and Splicing (3 papers). Junyong Zhao collaborates with scholars based in China, United States and Australia. Junyong Zhao's co-authors include Lin Fang, Deng‐Feng Li, Hongming Song, Bingkun Zhao, Hui Xu, Tianqi Wu, Dan Xie, Jiashu Hu, Chenyang Wu and Yixiang Huang and has published in prestigious journals such as RSC Advances, Cell Death and Disease and Oncotarget.

In The Last Decade

Junyong Zhao

24 papers receiving 614 citations

Peers

Junyong Zhao
Rosario Avolio Italy
Beilei Zeng China
Xiyin Wei China
Miaoxin Zhu China
Guo-Sheng Hu China
Dahong Zhang China
Xin Sui China
Yunyun Xiao China
Hua Guan China
Rosario Avolio Italy
Junyong Zhao
Citations per year, relative to Junyong Zhao Junyong Zhao (= 1×) peers Rosario Avolio

Countries citing papers authored by Junyong Zhao

Since Specialization
Citations

This map shows the geographic impact of Junyong Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyong Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyong Zhao more than expected).

Fields of papers citing papers by Junyong Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyong Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyong Zhao. The network helps show where Junyong Zhao may publish in the future.

Co-authorship network of co-authors of Junyong Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Junyong Zhao. A scholar is included among the top collaborators of Junyong Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyong Zhao. Junyong Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Wenjian, Wen Li, Junyong Zhao, et al.. (2024). The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective Study. Journal of Cardiothoracic Surgery. 19(1). 571–571. 1 indexed citations
2.
Zhao, Junyong, Tao Yan, Yuying Wang, et al.. (2024). ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway. Cell Death and Disease. 15(4). 260–260. 8 indexed citations
3.
Li, Kunyan, Ping Hu, Xiaolin Luo, et al.. (2024). Anomalous origin of the coronary artery: prevalence and coronary artery disease in adults undergoing coronary tomographic angiography. BMC Cardiovascular Disorders. 24(1). 271–271. 1 indexed citations
4.
Sun, Ning, Junyong Zhao, Wenjian Luo, et al.. (2024). Description and Prognosis of Patients with Recovered Dilated Cardiomyopathy: A Retrospective Cohort Study. Reviews in Cardiovascular Medicine. 25(7). 246–246.
5.
6.
7.
Zhang, Yupeng, et al.. (2023). Research on digital energy carbon management platform and services for energy-using companies under the “3060” target. IOP Conference Series Earth and Environmental Science. 1171(1). 12019–12019. 1 indexed citations
8.
Yang, Lili, Ning Sun, Xiaolin Luo, et al.. (2023). Impact of coronary artery disease in patients with hypertrophic cardiomyopathy. Hellenic Journal of Cardiology. 77. 27–35. 3 indexed citations
9.
Peng, Liang, Di Liu, Haiyang Liu, et al.. (2022). Bombesin receptor-activated protein exacerbates cisplatin-induced AKI by regulating the degradation of SIRT2. Nephrology Dialysis Transplantation. 37(12). 2366–2385. 5 indexed citations
10.
Zhao, Junyong, et al.. (2022). Data Quality Evaluation of Photovoltaic Power Station based on Entropy Weight Method and Grey Comprehensive Evaluation Method. Journal of Physics Conference Series. 2399(1). 12001–12001. 2 indexed citations
11.
Luo, Qifeng, Hongming Song, Xiaochong Deng, et al.. (2020). A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer. Molecular Therapy — Oncolytics. 16. 219–229. 19 indexed citations
12.
Song, Hongming, Qifeng Luo, Xiaochong Deng, et al.. (2019). VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer. Experimental & Molecular Medicine. 51(11). 1–13. 35 indexed citations
13.
Zhao, Junyong, Deng‐Feng Li, & Lin Fang. (2019). MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1. Biomedicine & Pharmacotherapy. 115. 108947–108947. 56 indexed citations
14.
15.
Huang, Yixiang, et al.. (2018). Overexpression of <em>HDAC9</em> is associated with poor prognosis and tumor progression of breast cancer in Chinese females. OncoTargets and Therapy. Volume 11. 2177–2184. 21 indexed citations
16.
Li, Deng‐Feng, Hongming Song, Tianqi Wu, et al.. (2017). MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1. Molecular and Cellular Biochemistry. 444(1-2). 169–178. 37 indexed citations
17.
Li, Dengfeng, Hongming Song, Tianqi Wu, et al.. (2017). MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility. RSC Advances. 7(82). 52030–52038. 8 indexed citations
18.
Huang, Yixiang, et al.. (2017). Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism. Xenobiotica. 48(8). 839–844. 23 indexed citations
19.
Hua, Kaiyao, Jiali Jin, Junyong Zhao, et al.. (2016). miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. International Journal of Oncology. 48(5). 1997–2006. 69 indexed citations
20.
Shen, Lei, Jia Li, Liping Xu, et al.. (2011). miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Experimental and Therapeutic Medicine. 3(3). 475–480. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosario Avolio Breakdown of academic impact, for papers by Beilei Zeng Breakdown of academic impact, for papers by Xiyin Wei Breakdown of academic impact, for papers by Miaoxin Zhu Breakdown of academic impact, for papers by Guo-Sheng Hu Breakdown of academic impact, for papers by Dahong Zhang Breakdown of academic impact, for papers by Xin Sui Breakdown of academic impact, for papers by Yunyun Xiao Breakdown of academic impact, for papers by Hua Guan
Rankless by CCL
2026